Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

Seung Woo Cho,Sojung Kim,Jong Min Kim,Jin-Soo Kim

DOI: https://doi.org/10.1038/nbt.2507

IF: 46.9

2013-01-29

Nature Biotechnology

Abstract:The genome of human cells is edited using the bacterial RNA-guided Cas9 endonuclease.

biotechnology & applied microbiology

What problem does this paper attempt to address?

Genome engineering using the CRISPR-Cas9 system

F Ann Ran,Patrick D Hsu,Jason Wright,Vineeta Agarwala,David A Scott,Feng Zhang

DOI: https://doi.org/10.1038/nprot.2013.143

IF: 14.8

2013-10-24

Nature Protocols

Abstract:Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1–2 weeks, and modified clonal cell lines can be derived within 2–3 weeks.

biochemical research methods
CRISPR/Cas9‐Directed Genome Editing of Cultured Cells

Luhan Yang,Joyce L Yang,Susan Byrne,Joshua Pan,George M Church,Joyce L. Yang,George M. Church

DOI: https://doi.org/10.1002/0471142727.mb3101s107

2014-07-01

Current Protocols in Molecular Biology

Abstract:Human genome engineering has been transformed by the introduction of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) system found in most bacteria and archaea. Type II CRISPR/Cas systems have been engineered to induce RNA-guided genome editing in human cells, where small RNAs function together with Cas9 nucleases for sequence-specific cleavage of target sequences. Here we describe the protocol for Cas9-mediated human genome engineering, including construct building and transfection methods necessary for delivering Cas9 and guide RNA (gRNA) into human-induced pluripotent stem cells (hiPSCs) and HEK293 cells. Following genome editing, we also describe methods to assess genome editing efficiency using next-generation sequencing and isolate monoclonal hiPSCs with the desired modifications for downstream applications.
RNA-Guided Human Genome Engineering via Cas9

P. Mali,L. Yang,K. M. Esvelt,J. Aach,M. Guell,J. E. DiCarlo,J. E. Norville,G. M. Church

DOI: https://doi.org/10.1126/science.1232033

IF: 56.9

2013-01-03

Science

Abstract:Genome Editing Clustered regularly interspaced short palindromic repeats (CRISPR) function as part of an adaptive immune system in a range of prokaryotes: Invading phage and plasmid DNA is targeted for cleavage by complementary CRISPR RNAs (crRNAs) bound to a CRISPR-associated endonuclease (see the Perspective by van der Oost ). Cong et al. (p. 819 , published online 3 January) and Mali et al. (p. 823 , published online 3 January) adapted this defense system to function as a genome editing tool in eukaryotic cells.

multidisciplinary sciences
Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.

Zhenyu He,Kehkooi Kee

DOI: https://doi.org/10.1007/978-1-4939-6472-7_10

2016-01-01

Abstract:Gene targeting and editing is an essential tool for both basic research and clinical application such as gene therapy. Several endonucleases have been invented to fulfill these purposes, including zinc finger nucleases, TALEN, and CRISPR/Cas9. Although all of these systems can target DNA sequence with high efficiency, they also exert off-target effects and genotoxicity. The off-target effects might not hinder their usage in animal models because the correctly targeted cells can be selected for further studies. However, the off-target effects could cause mutations which may be damaging or cancerous to the patients. In this chapter, we describe a genome-editing nuclease method which relies on modifying specific amino acids on a monomeric endonuclease, I-SceI, to recognize a targeted sequence in the human genome. This nuclease is small in size and shows a much lower genotoxicity compared to other nucleases including CRISPR/Cas9.
CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Chengkun Wang,Qiong Xia,Qianhe Zhang,Yuanhao Qu,Stephen Su,Jason K. W. Cheng,Nicholas W. Hughes,Le Cong

DOI: https://doi.org/10.3389/fcell.2021.719705

IF: 5.5

2022-06-14

Frontiers in Cell and Developmental Biology

Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

cell biology,developmental biology
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases

Seung Woo Cho,Sojung Kim,Yongsub Kim,Jiyeon Kweon,Heon Seok Kim,Sangsu Bae,Jin-Soo Kim

DOI: https://doi.org/10.1101/gr.162339.113

IF: 9.438

2013-11-19

Genome Research

Abstract:RNA-guided endonucleases (RGENs), derived from the prokaryotic adaptive immune system known as CRISPR/Cas, enable targeted genome engineering in cells and organisms. RGENs are ribonucleoproteins that consist of guide RNA and Cas9, a protein component originated from Streptococcus pyogenes . These enzymes cleave chromosomal DNA, whose sequence is complementary, to guide RNA in a targeted manner, producing site-specific DNA double-strand breaks (DSBs), the repair of which gives rise to targeted genome modifications. Despite broad interest in RGEN-mediated genome editing, these nucleases are limited by off-target mutations and unwanted chromosomal translocations associated with off-target DNA cleavages. Here, we show that off-target effects of RGENs can be reduced below the detection limits of deep sequencing by choosing unique target sequences in the genome and modifying both guide RNA and Cas9. We found that both the composition and structure of guide RNA can affect RGEN activities in cells to reduce off-target effects. RGENs efficiently discriminated on-target sites from off-target sites that differ by two bases. Furthermore, exome sequencing analysis showed that no off-target mutations were induced by two RGENs in four clonal populations of mutant cells. In addition, paired Cas9 nickases, composed of D10A Cas9 and guide RNA, which generate two single-strand breaks (SSBs) or nicks on different DNA strands, were highly specific in human cells, avoiding off-target mutations without sacrificing genome-editing efficiency. Interestingly, paired nickases induced chromosomal deletions in a targeted manner without causing unwanted translocations. Our results highlight the importance of choosing unique target sequences and optimizing guide RNA and Cas9 to avoid or reduce RGEN-induced off-target mutations.

genetics & heredity,biochemistry & molecular biology,biotechnology & applied microbiology
Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

Qiupeng Zheng,Xiaohong Cai,Meng How Tan,Steven Schaffert,Christopher P Arnold,Xue Gong,Chang-Zheng Chen,Shenglin Huang

DOI: https://doi.org/10.2144/000114196

2014-01-01

BioTechniques

Abstract:The prokaryotic type II CRISPR/Cas9 system has been adapted to perform targeted genome editing in cells and model organisms. Here, we describe targeted gene deletion and replacement in human cells via the CRISPR/Cas9 system using two guide RNAs. The system effectively generated targeted deletions of varied length, regardless of the transcriptional status of the target gene. It is notable that targeted gene deletions generated via CRISPR/Cas9 and two guide RNAs resulted in the formation of correct junctions at high efficiency. Moreover, in the presence of a homology repair donor, the CRISPR/Cas9 system could guide precise gene replacement. Our results illustrate that the CRISPR/Cas9 system can be used to precisely and effectively generate targeted deletions or gene replacement in human cells, which will facilitate characterization of functional domains in protein-coding genes as well as noncoding regulatory sequences in animal genomes.
Precise Gene Deletion and Replacement Using the CRISPR/Cas9 System in Human Cells

Qiupeng Zheng,Xiaohong Cai,Meng How Tan,Steven Schaffert,Christopher P. Arnold,Xue Gong,Chang-Zheng Chen,Shenglin Huang

DOI: https://doi.org/10.2144/000114196

2014-01-01

BioTechniques

Abstract:The prokaryotic type II CRISPR/Cas9 system has been adapted to perform targeted genome editing in cells and model organisms. Here, we describe targeted gene deletion and replacement in human cells via the CRISPR/Cas9 system using two guide RNAs. The system effectively generated targeted deletions of varied length, regardless of the transcriptional status of the target gene. It is notable that targeted gene deletions generated via CRISPR/Cas9 and two guide RNAs resulted in the formation of correct junctions at high efficiency. Moreover, in the presence of a homology repair donor, the CRISPR/Cas9 system could guide precise gene replacement. Our results illustrate that the CRISPR/Cas9 system can be used to precisely and effectively generate targeted deletions or gene replacement in human cells, which will facilitate characterization of functional domains in protein-coding genes as well as noncoding regulatory sequences in animal genomes.
Development and application of CRISPR/Cas9 technologies in genomic editing.

Cui Zhang,Renfu Quan,Jinfu Wang

DOI: https://doi.org/10.1093/hmg/ddy120

IF: 5.1214

2018-01-01

Human Molecular Genetics

Abstract:Genomic editing to correct disease-causing mutations is a promising approach for the treatment of human diseases. As a simple and programmable nuclease-based genomic editing tool, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has substantially improved the ability to make precise changes in the human genome. Rapid development of CRISPR-based technologies in recent years has expanded its application scope and promoted CRISPR-based therapies in preclinical trails. Here, we review the application of the CRISPR system over the last 2 years; including its development and application in base editing, transcription modulation and epigenetic editing, genomic-scale screening, and cell and embryo therapy. Finally, the prospects and challenges related to application of CRISPR/Cas9 technologies are discussed.
Target residence of Cas9: challenges and opportunities in genome editing

Yi-Li Feng,Meng Wang,An-Yong Xie

DOI: https://doi.org/10.1007/s42764-022-00066-1

2022-01-01

Genome Instability & Disease

Abstract:CRISPR/Cas9 genome editing is a latest success in biotechnology that repurposes a natural biological system for a practical tool in genetic engineering. Site-specific DNA double strand breaks (DSB) induced by the CRISPR nuclease Cas9 allows endogenous cellular repair apparatus to generate desired repair products. Residence of Cas9 on cleaved DNA conceals the DNA ends from recognition by response and repair apparatus, delaying DNA damage response (DDR) and repair. Thus, tight-binding and long residence of Cas9 on DNA target are proposed as a new determinant of DSB repair pathway choice and may collaborate with other endogenous pathway choice regulators to control DSB repair. Accordingly, harnessing the binding and resident behavior of Cas9 not only broadens the application of CRISPR/dCas9 platform, which at least in part depends upon the tight binding and long residence of dCas9, but also minimizes the undesired outcomes of CRISPR/Cas9 genome editing.
Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Jiali Pu,David Frescas,Baorong Zhang,Jian Feng

DOI: https://doi.org/10.1177/1535370215584932

2015-01-01

Experimental Biology and Medicine

Abstract:The capability to modify the genome precisely and efficiently offers an extremely useful tool for biomedical research. Recent developments in genome editing technologies such as transcription activator-like effector nuclease and the clustered regularly interspaced short palindromic repeats system have made genome modification available for a number of organisms with relative ease. Here, we introduce these genome editing techniques, compare and contrast each technical approach and discuss their potential to study the underlying mechanisms of human disease using patient-derived induced pluripotent stem cells.
Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Jiali Pu,David Frescas,Baorong Zhang,Jian Feng

DOI: https://doi.org/10.1177/1535370215584932

2015-01-01

Experimental Biology and Medicine

Abstract:The capability to modify the genome precisely and efficiently offers an extremely useful tool for biomedical research. Recent developments in genome editing technologies such as transcription activator-like effector nuclease and the clustered regularly interspaced short palindromic repeats system have made genome modification available for a number of organisms with relative ease. Here, we introduce these genome editing techniques, compare and contrast each technical approach and discuss their potential to study the underlying mechanisms of human disease using patient-derived induced pluripotent stem cells.
Guide for generating single-cell-derived knockout clones in mammalian cell lines using the CRISPR/Cas9 system

Taeyeon Hong,Seung-Min Bae,Gwonhwa Song,Whasun Lim

DOI: https://doi.org/10.1016/j.mocell.2024.100087

Abstract:Genome editing has developed rapidly in various research fields for targeted genome modifications in many organisms, including cells, plants, viruses, and animals. The clustered regularly interspaced short palindromic repeats-associated protein 9 system stands as a potent tool in gene editing for generating cells and animal models with high precision. The clinical potential of clustered regularly interspaced short palindromic repeats-associated protein 9 has been extensively reported, with applications in genetic disease correction, inhibition of viral replication, and personalized or targeted therapeutics for various cancers. In this study, we provide a guide on single-guide RNA design, cloning single-guide RNA into plasmid vectors, single-cell isolation via transfection, and identification of knockout clones using next-generation sequencing. In addition, by providing the results of insertion into mammalian cell lines through next-generation sequencing, we offer useful information to those conducting research on human and animal cell lines.
Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks

Alexandre Paix,Andrew Folkmann,Daniel H Goldman,Heather Kulaga,Michael J Grzelak,Dominique Rasoloson,Supriya Paidemarry,Rachel Green,Randall R Reed,Geraldine Seydoux,Daniel H. Goldman,Michael J. Grzelak,Randall R. Reed

DOI: https://doi.org/10.1073/pnas.1711979114

IF: 11.1

2017-11-28

Proceedings of the National Academy of Sciences

Abstract:Significance Genome editing, the introduction of precise changes in the genome, is revolutionizing our ability to decode the genome. Here we describe a simple method for genome editing in mammalian cells that takes advantage of an efficient mechanism for gene conversion that utilizes linear donors. We demonstrate that PCR fragments containing edits up to 1 kb require only 35-bp homology sequences to initiate repair of Cas9-induced double-stranded breaks in human cells and mouse embryos. We experimentally determine donor DNA design rules that maximize the recovery of edits without cloning or selection.

multidisciplinary sciences
CRISPR-Cas systems for editing, regulating and targeting genomes

Jeffry D Sander,J Keith Joung

DOI: https://doi.org/10.1038/nbt.2842

IF: 46.9

2014-03-02

Nature Biotechnology

Abstract:Targeted genome editing using engineered nucleases has rapidly gone from being a niche technology to a mainstream method used by many biological researchers. This widespread adoption has been largely fueled by the emergence of the clustered, regularly interspaced, short palindromic repeat (CRISPR) technology, an important new approach for generating RNA-guided nucleases, such as Cas9, with customizable specificities. Genome editing mediated by these nucleases has been used to rapidly, easily and efficiently modify endogenous genes in a wide variety of biomedically important cell types and in organisms that have traditionally been challenging to manipulate genetically. Furthermore, a modified version of the CRISPR-Cas9 system has been developed to recruit heterologous domains that can regulate endogenous gene expression or label specific genomic loci in living cells. Although the genome-wide specificities of CRISPR-Cas9 systems remain to be fully defined, the power of these systems to perform targeted, highly efficient alterations of genome sequence and gene expression will undoubtedly transform biological research and spur the development of novel molecular therapeutics for human disease.

biotechnology & applied microbiology
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis

Zhonggang Hou,Yan Zhang,Nicholas E. Propson,Sara E. Howden,Li-Fang Chu,Erik J. Sontheimer,James A. Thomson

DOI: https://doi.org/10.1073/pnas.1313587110

IF: 11.1

2013-08-12

Proceedings of the National Academy of Sciences

Abstract:Significance Genome engineering in human pluripotent stem cells holds great promise for biomedical research and regenerative medicine, but it is very challenging. Recently, an RNA-guided nuclease system called clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated (Cas) has been applied to genome engineering, greatly increasing the efficiency of genome editing. Here, using a CRISPR-Cas system identified in Neisseria meningitidis , which is distinct from the commonly used Streptococcus pyogenes system, we demonstrate efficient genome engineering in human pluripotent stem cells. Our study could have a tremendous impact in regenerative medicine.
Genome editing with natural and engineered CjCas9 orthologs

Siqi Gao,Yao Wang,Tao Qi,Jingjing Wei,Ziying Hu,Jingtong Liu,Shuna Sun,Huihui Liu,Yongming Wang

DOI: https://doi.org/10.1016/j.ymthe.2023.01.029

IF: 12.91

2023-04-01

Molecular Therapy

Abstract:CjCas9 is one of the smallest CRISPR-associated (Cas9) nucleases for mammalian genome editing. However, it requires a long N4RYAC (R = A or G; Y = C or T) protospacer-adjacent motif (PAM), limiting its DNA targeting scope. In this study, we investigated the PAMs of three CjCas9 orthologs, including Hsp1Cas9, Hsp2Cas9, and CcuCas9, by performing a GFP-activation assay. Interestingly, Hsp1Cas9 and CcuCas9 recognized unique N4RAA and N4CNA PAMs, respectively. We further generated an Hsp1Cas9-Hsp2Cas9 chimeric Cas9 (Hsp1-Hsp2Cas9), which recognized a simple N4CY PAM. Genome-wide off-target analysis revealed that Hsp1-Hsp2Cas9 has very few off-targets compared to SpCas9. By analyzing the crystal structure of CjCas9, we identified eight mutations that can improve the specificity and generate a high-fidelity Hsp1-Hsp2Cas9-Y. Hsp1-Hsp2Cas9-Y enables the knockout of B4GALNT2 and CMAH in porcine fetal fibroblasts (PFFs). Moreover, we developed a high-fidelity Hsp1-Hsp2Cas9-KY which displayed undetectable off-targets revealed by GUIDE-seq at four tested loci. These natural and engineered Cas9 nucleases enabled efficient genome editing in multiple mammalian cells, expanding the DNA targeting scope.

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
CRISPR-Cas9: A Precise Approach to Genome Engineering

Jorge E Simón,Ángel S Rodríguez,Nelson Santiago Vispo

DOI: https://doi.org/10.1177/2168479018762798

Abstract:In the last few decades, genomic manipulation has made significant progress as a result of the development of recombinant DNA technologies; however, more often than not, these techniques have been costly and labor intensive. In contrast, recently developed next-generation sequencing (NGS) technologies have provided a cheaper, faster, and easier process to study genomics. In particular, an NGS technique emerged from bacterial CRISPR-associated protein-9 nuclease (Cas9) as a revolutionary method to modify, regulate, or mark specific genomic sequences on virtually any organism. A later adaptation of this bacterial defense mechanism that successfully and permanently edits dysfunctional genes and corrects missing proteins has resulted in a new era for disease genetic engineering. Clinical trials using this technique are already being performed, and the applicability of CRISPR-Cas9 techniques is actively being investigated using in vivo studies. However, the concept of genome correction poses great concerns from a regulatory perspective, especially in terms of security, so principles for the regulation of these methodologies are being established. We delved into CRISPR-Cas9 from its natural and ortholog origins to its engineered variants and behaviors to present its notable and diverse applications in the fields of biotechnology and human therapeutics.
Utilization of nicking properties of CRISPR-Cas12a effector for genome editing

Chan Hyoung Kim,Wi-jae Lee,Yeounsun Oh,Youngjeon Lee,Hyomin K. Lee,Jung Bae Seong,Kyung-Seob Lim,Sang Je Park,Jae-Won Huh,Young-Hyun Kim,Kyoung Mi Kim,Junho K. Hur,Seung Hwan Lee

DOI: https://doi.org/10.1038/s41598-024-53648-2

IF: 4.6

2024-02-11

Scientific Reports

Abstract:The CRISPR-Cas nickase system for genome editing has attracted considerable attention owing to its safety, efficiency, and versatility. Although alternative effectors to Cas9 have the potential to expand the scope of genome editing, their application has not been optimized. Herein, we used an enhanced CRISPR-Cas12a nickase system to induce mutations by targeting genes in a human-derived cell line. The optimized CRISPR-Cas12a nickase system effectively introduced mutations into target genes under a specific directionality and distance between nickases. In particular, the single-mode Cas12a nickase system can induce the target-specific mutations with less DNA double-strand breaks. By inducing mutations in the Thymine-rich target genes in single- or dual-mode, Cas12a nickase compensates the limitations of Cas9 nickase and is expected to contribute to the development of future genome editing technologies.

multidisciplinary sciences
Orthogonal Chemical Activation of Enzyme-Inducible CRISPR/Cas9 for Cell-Selective Genome Editing.

Weiqi Cai,Ji Liu,Xianghan Chen,Lanqun Mao,Ming Wang

DOI: https://doi.org/10.1021/jacs.2c10545

IF: 15

2022-01-01

Journal of the American Chemical Society

Abstract:The precision and therapeutic potential of CRISPR/Cas9 genome editing are greatly challenged by the less control over Cas9-mediated DNA cleavage. Herein, we introduce a conditional and cell-selective genome editing system controlled by disease-associated enzymes, termed enzyme-inducible CRISPR (eiCRISPR). eiCRISPR comprises Cas9 protein, a self-blocked inactive single-guide RNA (bsgRNA), and a chemically caged deoxyribozyme (DNAzyme) that activates bsgRNA and eiCRISPR in a controllable manner. We design chemical modifications of DNAzyme to suppress its ability to cleave the blocking region of bsgRNA, while the decaging of DNAzyme triggered by the tumor cell-overexpressed enzyme, for instance, NAD(P)H:quinone oxidoreductase (NQO1), restores the activity of bsgRNA and switches on eiCRISPR selectively for genome editing in cancer cells. Moreover, using a biodegradable lipid nanoparticle to deliver eiCRISPR in a tumor-bearing xenograft, we show that the in vivo activation of eiCRISPR enables the editing of human papillomavirus 18 E6 for potential cancer therapy. The strategy of postsynthetic and site-specific modification of DNAzyme is compatible with endogenous chemistries for regulating eiCRISPR for cell-selective genome editing and targeted gene therapy.

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

Genome engineering using the CRISPR-Cas9 system

CRISPR/Cas9‐Directed Genome Editing of Cultured Cells

RNA-Guided Human Genome Engineering via Cas9

Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

Precise Gene Deletion and Replacement Using the CRISPR/Cas9 System in Human Cells

Development and application of CRISPR/Cas9 technologies in genomic editing.

Target residence of Cas9: challenges and opportunities in genome editing

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Guide for generating single-cell-derived knockout clones in mammalian cell lines using the CRISPR/Cas9 system

Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks

CRISPR-Cas systems for editing, regulating and targeting genomes

Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis

Genome editing with natural and engineered CjCas9 orthologs

CRISPR-Cas9: A Precise Approach to Genome Engineering

Utilization of nicking properties of CRISPR-Cas12a effector for genome editing

Orthogonal Chemical Activation of Enzyme-Inducible CRISPR/Cas9 for Cell-Selective Genome Editing.